Evidence map›Paper›PMID 42143263›Full record

ArticleBMC medical imaging2026

MTRFU-Net: a lung nodule segmentation model based on improved U-Net architecture with spatial-frequency fusion.

Yuting Wu, Bin Li

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuting WuCollege of Engineering Science and Technology, Shanghai Ocean University, Shanghai, 201306, China.
Bin LiMedical Equipment Department, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital, Shanghai, 200233, China. Libin2001@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate pulmonary nodule segmentation is a key step for the early diagnosis of lung cancer, yet existing deep learning methods still have limitations in addressing challenges such as nodule heterogeneity, blurred boundaries, and multi-scale variations. To tackle these issues, this study proposes the MTRFU-Net model, a pulmonary nodule segmentation model based on an improved U-Net architecture integrating spatial-frequency features and multi-module collaboration, which adopts a three-tier progressive module collaboration strategy to achieve dynamic spatial-frequency fusion. The encoder of the model is built on ResNet50 and incorporates a Spatial-Frequency Fusion (SFF) module, enabling the parallel extraction and dynamic fusion of dual-domain features. The bottleneck layer combines a Transformer encoder with an optimized Atrous Spatial Pyramid Pooling (ASPP) module, effectively capturing long-range dependencies and multi-scale contextual information. For the decoder, residual connections are paired with a dynamically weighted scSE attention mechanism to enhance the response capability to critical features. Extensive experiments on the LIDC-IDRI dataset demonstrate that MTRFU-Net exhibits excellent performance in terms of the Dice Similarity Coefficient (DSC), mean Intersection over Union (mIoU). This research validates the effectiveness of frequency-domain information in pulmonary nodule segmentation tasks, providing valuable references for the development of robust clinically oriented segmentation models.

Indexed as

Deep LearningLung NeoplasmsSolitary Pulmonary NoduleTomography, X-Ray ComputedConvolutional Neural NetworksHumansDeep learningFast fourier transformLung nodule segmentationMulti-scale featuresU-Net

Identifiers

PMID42143263
PMCPMC13366801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.